PI
NXTM

Putnam Investments’s NxStage Medical Inc. NXTM Stock Holding History

Putnam Investments’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-34,184
Closed -$857K – 1238
2017
Q2 		$857K Buy
+34,184
New +$846K ﹤0.01% 923
2014
Q3 		– Sell
-89,972
Closed -$1.29M – 1551
2014
Q2 		$1.29M Buy
89,972
+112
+0.1% +$1.46K ﹤0.01% 1135
2014
Q1 		$1.15M Sell
89,860
-4,586
-5% -$59.8K ﹤0.01% 1172
2013
Q4 		$945K Sell
94,446
-1,389
-1% -$15.8K ﹤0.01% 1218
2013
Q3 		$1.26M Sell
95,835
-8,429
-8% -$111K ﹤0.01% 1170
2013
Q2 		$1.49M Buy
+104,264
New +$1.31M ﹤0.01% 1131

Other funds holding NXTM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Putnam Investments's NXTM Position: Q3 2017 in Review

Putnam Investments sold out of NxStage Medical Inc. (NXTM) in Q3 2017, closing a stake of 34,184 shares — an estimated $857K sold.

Putnam Investments first reported a position in NXTM in Q2 2013 and held it in 6 quarters. The position peaked at $1.49M in Q2 2013. 168 funds tracked by Wall St. Rank hold NXTM as of Q3 2017.

  • Putnam Investments reported no remaining NxStage Medical Inc. position as of Q3 2017 after selling out during the quarter.
  • Putnam Investments sold 34,184 NxStage Medical Inc. shares in Q3 2017, an estimated $857K.
  • Putnam Investments first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 6 quarters.
  • Putnam Investments's NxStage Medical Inc. position peaked at $1.49M in Q2 2013.
  • 168 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2017.

Based on Putnam Investments's 13F filing for Q3 2017, filed 14 Nov 2017.